Navigation Links
Kensey Nash to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
Date:4/30/2009

EXTON, Pa., April 30 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Bank of America and Merrill Lynch 2009 Health Care Conference at The Palace Hotel in New York, on Wednesday, May 13, 2009.

Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's presentation, beginning at approximately 1:20 p.m. (ET). To hear the live webcast of the Kensey Nash presentation go to http://www.veracast.com/webcasts/bas/healthcare09/id78208658.cfm. The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 1:20 p.m. (ET) on Wednesday, May 13, 2009.

About Kensey Nash Corporation. Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, including sports medicine, spine, and endovascular. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.


'/>"/>
SOURCE Kensey Nash Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results
2. Kensey Nash Corporation Announces Its Third Quarter 2009 Earnings Release Date and Teleconference
3. Kensey Nash Announces 600,000 Share Stock Repurchase Program
4. Kensey Nash to Participate in the Sidoti Thirteenth Annual New York Emerging Growth Institutional Investor Forum Conference
5. Kensey Nash Announces Appointment of Chief Financial Officer
6. Kensey Nash to Present at the Canaccord Adams Musculoskeletal Conference
7. Kensey Nash Announces Director Resignation
8. Kensey Nash Corporation Announces Its Second Quarter 2009 Earnings Release Date and Teleconference
9. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
10. Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2008 Earnings Release Date and Teleconference
11. Kensey Nash Provides 4th Quarter Fiscal 2008 and Fiscal Year 2009 Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2017)... Aliso Viejo, California (PRWEB) , ... January 15, 2017 , ... ... create a stylistic slideshow with complete customization and ease," said Christina Austin - CEO ... variety of controls so that users can edit the style and animation of their ...
(Date:1/15/2017)... ... January 15, 2017 , ... The JPR ... pleased to announce that it will be assisting HackensackUMC Mountainside with its public ... Ridge townships, servicing all surrounding towns. The firm will be working closely with ...
(Date:1/14/2017)... ... ... Volume 3 is a self animating masking transition which allows users to reveal any object ... Austin - CEO of Pixel Film Studios. , TransFreeze Volume 3 provides FCPX ... the next. , To use “Cut-Out First” presets, choose a video clip and ...
(Date:1/13/2017)... , ... January 13, 2017 , ... KOAMTAC ®, ... will be showcasing the next generation companion scanner and data collector at the National ... KDC270 has been created as an answer to the market’s need for more compact ...
(Date:1/13/2017)... ... January 13, 2017 , ... People who have sensitive teeth are about as ... brush their teeth. Sadly, most dental hygiene products in the market contain chemical ingredients ... these people, continuing their daily oral care routine to keep their teeth white and ...
Breaking Medicine News(10 mins):
(Date:1/14/2017)... , Jan. 14, 2017  Johnson & Weaver, LLP ... of purchasers of Zimmer Biomet Holdings, Inc. (NYSE: ... through October 31, 2016 (the "Class Period"). Zimmer ... and markets orthopaedic reconstructive products, such as knee and hip ... ...
(Date:1/13/2017)... , January 13, 2017 Constant research ... AIDS will collectively contribute to the demand for western blotting ... a value of US$ 551.0 Mn by 2016 end. Developing ... the most lucrative markets for western blotting, whereas ... globally. ...
(Date:1/13/2017)... YORK , January 13, 2017 ... equities to see how they have fared at yesterday,s ... ), Galena Biopharma Inc. (NASDAQ: GALE ), ... These companies harness cellular and biomolecular processes to develop ... reduce our environmental footprint, feed the hungry, use less ...
Breaking Medicine Technology: